Esthetic outcome of surgical excision versus antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis in children.

Abstract	One hundred children with microbiologically proven nontuberculous mycobacterial cervicofacial lymphadenitis were randomly assigned to excision of the involved lymph nodes, or antibiotic therapy consisting of clarithromycin and rifabutin. The esthetic outcome was rated using a revised and weighted Observer Scar Assessment Scale. The median weighted esthetic outcome in surgical patients was significantly better (30.6) than that for patients treated with antibiotics (42.2).
Authors	Jerome A Lindeboom, Robert Lindeboom, Elisabeth S Bruijnesteijn van Coppenraet, Ed J Kuijper, Jacco Tuk, Jan M Prins
Journal	The Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 28 Issue 11 Pg. 1028-30 (Nov 2009) ISSN: 1532-0987 [Electronic] United States
PMID	19773678 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References	Anti-Bacterial Agents Rifabutin Clarithromycin
Topics	Adolescent Anti-Bacterial Agents (therapeutic use) Child Child, Preschool Clarithromycin (therapeutic use) Female Humans Infant Lymph Node Excision Lymphadenitis (drug therapy, surgery) Male Mycobacterium Infections (drug therapy, surgery) Rifabutin (therapeutic use) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!